Copyright © 2002 by the European Society of Cardiology.
Letters to the Editor
The abrupt no-flow: a no-reflow like phenomenon in hypertrophic cardiomyopathy
The Bielefeld Klinikum, Department of Medicinel Cardiology, Bielefeld, Germany
References
- Cuccurullo F, Mezzetti A, Lapenna D. Mechanisms of isoproterenol-induced angina pectoris in patients with obstructive hypertrophic cardiomyopathy and normal coronary arteries. Am J Cardiol. 1987;60:667673[CrossRef][ISI][Medline]
- Dimitrow PP, Krzanowski M, Nizankowski R, Szczeklik A, Dubiel JS. Comparison of the effect of verapamil and propranolol on response of coronary vasomotion to cold pressor test in symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther. 2000;14:643650[CrossRef][ISI][Medline]
- Kuhn H, Seggewiss H, Gietzen F. Catheter interventional therapy for HOCM: first two year analysis of the National Registry of the German Cardiac Society. Eur Heart J (Abstr Suppl). 2000;21:413
- Kim JJ, Lee CW, Park SW. Improvement in exercise capacity and exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophic cardiomyopathy. Am J Cardiol. 1999;83:12201223[CrossRef][ISI][Medline]
- Kuhn H, Gietzen F, Leuner CH, Gehrenkamp T. Induction of subaortic septal ischemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter based concept of treatment. Eur Heart J. 1997;18:846851
[Abstract/Free Full Text] - Kuhn H, Gietzen FH, Leuner CH. Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy. Z Kardiol. 2000;89:4154
- Olivotto I, Maron BI, Montereggi A, Mazzuoli F, Dolora A, Cecchi F. Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1999;33:20442051
[Abstract/Free Full Text] - Limbruno U, Strata G, Zucchi R. Altered autonomic cardiac control in hypertrophic cardiomyopathy. Eur Heart J. 1998;19:146153
[Abstract/Free Full Text] - Meirhaeghe A, Bauters C, Helbecque N. The human G-protein ß3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. Eur Heart J. 2001;22:845848
[Abstract/Free Full Text] - Shirani J, Pick R, Roberts WC, Maron BI. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol. 2000;35:3644
[Abstract/Free Full Text] - Bishop N, Rees MR. Idiosyncratic reaction to intracoronary injection of non-ionic contrast media. Clin Radiol. 1988;39:396397[CrossRef][ISI][Medline]
- Mauser M, Dittmann H, Voelker W, Kühlkamp V, Karsch KR. Occlusive spasm of the left coronary artery during coronary angiography. Z Kardiol. 1990;79:654658[ISI][Medline]
- Laskey W, Boyle J, Johnson L. Multivariable model for prediction of risk of significant complication during diagnostic cardiac catheterization. Cath Cardiovasc Diagnosis. 1993;30:185190
- Wu DJ, Ueng KC, Lin CS. Multivessel spasm during coronary angiographic procedure in catheterization laboratory. Acta Cardiologica Sinica. 1999;15:4550
This article has been cited by other articles:
![]() |
F H Gietzen, C J Leuner, L Obergassel, C Strunk-Mueller, and H Kuhn Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients Heart, June 1, 2004; 90(6): 638 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1687 - 1713. [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Eur. Heart J., November 1, 2003; 24(21): 1965 - 1991. [Full Text] [PDF] |
||||
![]() |
F. H. Gietzen, C. J. Leuner, L. Obergassel, C. Strunk-Mueller, and H. Kuhn Role of Transcoronary Ablation of Septal Hypertrophy in Patients With Hypertrophic Cardiomyopathy, New York Heart Association Functional Class III or IV, and Outflow Obstruction Only Under Provocable Conditions Circulation, July 23, 2002; 106(4): 454 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.P. Dimitrow and J.S. Dubiel Impairment of coronary microvascular flow in hypertrophic cardiomyopathy Eur. Heart J., June 2, 2002; 23(12): 991 - 991. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



